{"abstract": "A federal judge in California ruled against Allergan, which was hoping its lawsuit against Valeant and Pershing Square Capital Management might prevent its shareholders from calling a special meeting until the case was resolved.", "web_url": "https://dealbook.nytimes.com/2014/08/21/botox-maker-allergans-suit-against-valeant-wont-delay-special-meeting/", "snippet": "A federal judge in California ruled against Allergan, which was hoping its lawsuit against Valeant and Pershing Square Capital Management might prevent its shareholders from calling a special meeting until the case was resolved.", "lead_paragraph": "Updated, 7:00 p.m. | When Allergan, the maker of Botox, sued Valeant Pharmaceuticals and Pershing Square Capital Management this month in a federal court in California, claiming insider trading, its opponents said the suit was an attempt to prevent shareholders from calling a special meeting until the case was resolved. Pershing Square, Allergan\u2019s largest shareholder, is pressing for a special meeting as it pursues a hostile takeover of the company with its partner, Valeant. ", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "xlarge", "caption": null, "credit": null, "type": "image", "url": "images/2014/08/22/business/dbpix-botox/dbpix-botox-articleLarge.jpg", "height": 430, "width": 600, "subType": "xlarge", "crop_name": "articleLarge", "legacy": {"xlarge": "images/2014/08/22/business/dbpix-botox/dbpix-botox-articleLarge.jpg", "xlargewidth": 600, "xlargeheight": 430}}, {"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2014/08/22/business/dbpix-botox/dbpix-botox-jumbo.jpg", "height": 733, "width": 1024, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "superJumbo", "caption": null, "credit": null, "type": "image", "url": "images/2014/08/22/business/dbpix-botox/dbpix-botox-superJumbo.jpg", "height": 1002, "width": 1399, "subType": "superJumbo", "crop_name": "superJumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2014/08/22/business/dbpix-botox/dbpix-botox-thumbStandard.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2014/08/22/business/dbpix-botox/dbpix-botox-thumbStandard.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}, {"rank": 0, "subtype": "thumbLarge", "caption": null, "credit": null, "type": "image", "url": "images/2014/08/22/business/dbpix-botox/dbpix-botox-thumbLarge.jpg", "height": 150, "width": 150, "subType": "thumbLarge", "crop_name": "thumbLarge", "legacy": {}}], "headline": {"main": "Botox Maker Allergan\u2019s Suit Against Valeant Won\u2019t Delay Special Meeting", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Insider Trading", "rank": 1, "major": "N"}, {"name": "subject", "value": "Suits and Litigation (Civil)", "rank": 2, "major": "N"}, {"name": "organizations", "value": "ALLERGAN INC", "rank": 3, "major": "N"}, {"name": "organizations", "value": "Pershing Square Capital Management", "rank": 4, "major": "N"}, {"name": "organizations", "value": "Valeant Pharmaceuticals International Inc", "rank": 5, "major": "N"}], "pub_date": "2014-08-21T22:05:24+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By David Gelles", "person": [{"firstname": "David", "middlename": null, "lastname": "Gelles", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/c63a2176-b9c0-5ac2-80ef-3abe6f01eb47", "word_count": 348, "uri": "nyt://article/c63a2176-b9c0-5ac2-80ef-3abe6f01eb47"}